This site is intended for Healthcare Professionals only.

Kasper Künzel appointed as interim vice president and general manager of Leo Pharma UK and Ireland

Date:

Share post:

Leo Pharma, one of the leaders in medical dermatology, has appointed Kasper Künzel as Interim Vice President and General Manager for its UK and Ireland business.

Kasper is an established leader within Leo Pharma, having previously been Vice President, IPO Preparedness Office, at Leo Pharma in Denmark.

Kasper brings over 17 years of pharmaceutical experience, previously taking on local and global leadership positions across Leo Pharma in functions including R&D, Finance and Commercial. Having first joined Leo Pharma in Denmark in a financial function, his previous roles include General Manager in South Korea, Vice President of Corporate Transformation, and Director of R&D Business Finance

He commented: “I am delighted to join the Leo Pharma UK and Ireland team and continue to build on the company’s strong heritage in these markets. The UK and Ireland team are committed to the Leo Pharma values as a leader in medical dermatology, and I’m looking forward to all we can achieve together this year.

My priorities in this new role will be to understand the key challenges and opportunities in the UK and Ireland – not only for Leo Pharma as a business, but also what our partners and patients are facing – to ensure informed and strategic decisions deliver positive outcomes for the dermatology community and the business. I firmly believe in being externally focussed, whilst also building high performance teams and nurturing talent development. We have the potential and ambition to be the preferred dermatology care partner, improving people’s lives around the world, and I believe we have an exciting future ahead.”

Kasper is already in this interim role as of January 2023 and will remain in place until a permanent Vice President and General Manager for Leo Pharma UK and Ireland joins this business.

 

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

Whooping cough outbreak in England: 9 infant deaths in six months

A combination of factors, including a decline in vaccination uptake, is believed to be contributing to the rise...

Multiple sclerosis: England approves new jab that cuts hospital treatment time by 90%

In addition to significantly reducing treatment time for patients, the new multiple sclerosis injection could also save time...

NHS GP Patient survey2024 highlights positive pharmacy service experiences

According to the NHS survey, 49.7 per cent patients contacted a pharmacy via phone, practice websites (47.9 per...

NHS performance data highlights urgent need for government action

Commenting on the publication of the NHS monthly performance statistics Tim Gardner, Assistant Director of Policy at the...